Fresenius reported EUR10.46B in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Akzo Nobel AKZA:NA EUR 2.86B 9M
Alcon AG ALC:SW USD 2.14B 77M
AstraZeneca AZN:LN USD 10.98B 211M
BASF BAS:GR EUR 21.95B 1.03B
Bayer BAYN:GR EUR 11.28B 1.54B
Beiersdorf BEI:GR EUR 2.25B 39M
Davita Healthcare Partners DVA:US USD 2.95B 21.94M
E.ON EOAN:GR EUR 28.75B 759M
Essilor EI:FP EUR 11.99B 942M
Fresenius FRE:GR EUR 10.46B 441M
Fresenius Medical Care FME:GR EUR 5.1B 339.17M
Fresenius Medical Care FMS:US EUR 5.1B 339.49M
Getinge GETIB:SS SEK 6.94B 271M
Givaudan GIVN:VX CHF 3.65B 341M
GlaxoSmithKline GSK:LN GBP 7.38B 453M
GN Store Nord GN:DC DKK 4.7B 156M
Hikma Pharmaceutical HIK:LN USD 1.21B 124M
Merck MRK:GR EUR 5.81B 238M
Novartis NOVN:VX USD 12.84B 243M
Philips PHIA:NA EUR 5.42B 1.11B
Roche Holding ROG:VX CHF 32.3B 207M
RWE RWE:GR EUR 10.74B 2.5B
Smith & Nephew PLC SN/:LN 2.6B 13M
William Demant Holding WDH:DC DKK 9.5B 121M